Skip to main content

Antiischemic, antianginal, and hemodynamic effects of ULFS 49 CL (a new heart-rate-reducing agent) in patients with angiographically proven CAD

  • Conference paper
Sinus node inhibitors

Abstract

ULFS 49 CL, a so-called sinus node inhibitor, does not affect β-adrenergic or muscarinic receptors at therapeutical plasma concentrations in man. The compound’s underlying mechanism of action to decrease heart rate can be explained by an inhibition of the if-current, which seems to be responsible for the spontaneous depolarization of the pacemaker cells in the sino-atrial node [1, 2]. Like β-blockers, the substance is expected to produce a reduction in heart rate. Through this mechanism ULFS 49 CL may result in antianginal and/or antiischemic efficacy in patients with angina pectoris. At present, no data are available on its antiischemic potential. The aim of the present multicenter trial was to investigate the antianginal, antiischemic, and hemodynamic effects of ULFS 49 CL, a new heart-rate-reducing compound, in patients with stable angina pectoris.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Similar content being viewed by others

References

  1. Lillie C, Kobinger W (1986) Investigations into the bradycardic effects of ULFS 49 CL (l,3,4,5-tetrahydro-7,8-dimethoxy-3-3-(3-k((2-(3,4-dimethoxyphenyl))ethyl) methyliminopropyl)-2H-3-benzazepin-2-on-hydrochloride) in isolated guinea pig atria. J Cardiovasc Pharmacol 8: 791–797.

    PubMed  CAS  Google Scholar 

  2. Krumpl G, Schneider W, Raberger G (1986) Can exercise-induced regional contractile dysfunction be prevented by selective bradycardic agents? Naunyn-Schmiedebergs Arch Pharmacol 334: 540–543.

    Article  PubMed  CAS  Google Scholar 

  3. Le CG (1987) On testing a trend in means in oneway layout. Biometrical Journal 29 /2: 173–180.

    Article  Google Scholar 

  4. Morrison DF (Multivariate statistical methods. International Student Edition. McGraw-Hill International Book Company. Auckland Bogota Guatema Hamburg Johannesburg Lisbon London Madrid Mexico New Delhi Panama Paris San Juan Sao Paulo Singapore Sydney Tokyo. 2. Edition, 4th print 1982.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1991 Dr. Dietrich Steinkopff Verlag GmbH & Co. KG, Darmstadt

About this paper

Cite this paper

Pitschner, H.F. et al. (1991). Antiischemic, antianginal, and hemodynamic effects of ULFS 49 CL (a new heart-rate-reducing agent) in patients with angiographically proven CAD. In: Hjalmarson, Å., Remme, W.J. (eds) Sinus node inhibitors. Steinkopff. https://doi.org/10.1007/978-3-642-72458-9_5

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-72458-9_5

  • Publisher Name: Steinkopff

  • Print ISBN: 978-3-7985-0861-3

  • Online ISBN: 978-3-642-72458-9

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics